Covered recipient · General Payments record
ANETA TARASIUK-RUSEK
Allopathic & Osteopathic Physicians Internal Medicine Infectious Disease
General Payments · PY2018–2024
$575.98
- Reported across 31 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $323.13 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $92.06 | 4 |
| ABBVIE INC. | $43.24 | 2 |
| Insmed, Inc. | $42.74 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $26.86 | 1 |
| Daiichi Sankyo Inc. | $26.14 | 1 |
| Merck Sharp & Dohme Corporation | $21.20 | 1 |
| CVRx Inc. | $19.48 | 1 |
| Exact Sciences Corporation | $18.69 | 1 |
| AIMMUNE THERAPEUTICS, INC. | $18.38 | 1 |
| Paratek Pharmaceuticals, Inc. | $14.34 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $22.31 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106202319 | CMS |
| ABBVIE INC. | $20.93 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106202321 | CMS |
| AIMMUNE THERAPEUTICS, INC. | $18.38 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147006475 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $26.86 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118187595 | CMS |
| CVRx, Inc. | $19.48 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138736016 | CMS |
| Daiichi Sankyo Inc. | $26.14 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089489184 | CMS |
| Exact Sciences Corporation | $18.69 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114928268 | CMS |
| Insmed, Inc. | $22.06 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089563792 | CMS |
| Insmed, Inc. | $20.68 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089568365 | CMS |
| Lilly USA, LLC | $24.27 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136040378 | CMS |
| Lilly USA, LLC | $25.60 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136040460 | CMS |
| Lilly USA, LLC | $18.75 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136036769 | CMS |
| Lilly USA, LLC | $23.44 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136044418 | CMS |
| Merck Sharp & Dohme LLC | $21.20 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141923002 | CMS |
| Paratek Pharmaceuticals, Inc. | $14.34 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113921256 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.